Skip to content

Lucid Diagnostics LUCD Change In Fair Value Of Convertible Debt

Change In Fair Value Of Convertible Debt at other companies

PTH
Pelthos Therapeutics Inc.PTHS
$5.2M
PTH
Pelthos Therapeutics Inc.PTHS
$5.2M
VenHub Global, Inc.
 logo
VenHub Global, Inc. VHUB
$932.2K+1,414%
Jade Biosciences, Inc. Common Stock logo
Jade Biosciences, Inc. Common StockJBIO
$0-100%
GCT
GCT Semiconductor HoldingGCTS
-$1.29M-6,668%
BioSig Technologies, Inc. logo
BioSig Technologies, Inc.STEX
-$1.75M

Other financials

Income statement

See full
Revenue$1.3M+51.7%
Gross profit-$369.0K+49.0%
Operating income-$12.1M+3.0%
Net income-$13.9M+48.3%
EPS (diluted)-$0.10+60.0%

Balance sheet

See full
Cash & equivalents$27.9M+10.6%
Total debt$1.6M-35.1%
Total equity$4.0M+174%
Total assets$34.1M+3.9%

Cash flow

See full
Operating cash flow-$12.1M+2.9%
CapEx$215.0K+131%
Free cash flow-$12.3M+1.9%

Valuation

See full
Market cap$204.13M+58.5%
Enterprise value$177.85M+78.0%
P/S39.8×+10.2×

Profitability

See full
Gross margin-66.8%
Operating margin-959.6%-133pp
Net margin-876.7%-254pp
FCF margin-1,099.6%

Returns & leverage

See full
Return on equity-710.6%
Debt / equity0.4×
Current ratio1.1×+0.3×

Where this comes from

Reported directly by Lucid Diagnostics in its filing.

Tagged under the XBRL concept lucd:ChangeInFairValueOfConvertibleDebt.

The official record: Lucid Diagnostics’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Lucid Diagnostics's change in fair value of convertible debt.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Lucid Diagnostics's change in fair value of convertible debt?
Lucid Diagnostics (LUCD) reported change in fair value of convertible debt of -$1.86M in Q1 2026.
How has Lucid Diagnostics's change in fair value of convertible debt changed year-over-year?
Lucid Diagnostics's change in fair value of convertible debt increased by 87.2% year-over-year, from -$14.48M to -$1.86M.
What does change in fair value of convertible debt mean?
This metric reflects the non-cash gains or losses resulting from the periodic revaluation of convertible debt instruments held on the balance sheet. Fluctuations in this value are typically driven by changes in the company's underlying stock price, volatility, or interest rate environments. It provides insight into the financial impact of complex capital structures and potential dilution risks associated with debt-to-equity conversion features.